NEW YORK, Feb. 15, 2019 /PRNewswire/ -- WeissLaw
LLP is investigating possible breaches of fiduciary duty
and other violations of law by the Board of Directors of CAS
Medical Systems, Inc. ("CASM" or the "Company") (NASDAQ: CASM) in
connection with the proposed acquisition of the Company by Edwards
Lifesciences Corporation ("EW"). Under the terms of the
acquisition agreement, shareholders will receive $2.45 in cash for each CASM share they own.
If you own CASM shares and wish to discuss
this investigation or have any questions concerning this notice or
your rights or interests, please contact:
Joshua Rubin,
Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888)
593-4771
stockinfo@weisslawllp.com
Visit our
website
http://www.weisslawllp.com/cas-medical-inc/
Or follow us on Twitter @MarketsAlert
WeissLaw is investigating whether CASM's Board acted to maximize
shareholder value prior to entering into the agreement.
Notably, the acquisition of CASM is a strategic transaction which
EW hopes will propel it as an industry leader. According to
EW's Corporate Vice President, "the incorporation of [CASM]'s
FORE-SIGHT technology . . . will strengthen [EW]'s leadership
in smart monitoring technologies."
Given these facts, WeissLaw is concentrating its investigation
on whether CASM's Board conducted a fair process in agreeing to the
proposed acquisition, whether the proposed acquisition undervalues
the Company, and whether all material information related to the
proposed acquisition is fully and fairly disclosed.
WeissLaw LLP has litigated hundreds of stockholder class and
derivative actions for violations of corporate and fiduciary
duties. We have recovered over a billion dollars for
defrauded clients and obtained important corporate governance
relief in many of these cases. If you have information or
would like legal advice concerning possible corporate wrongdoing
(including insider trading, waste of corporate assets, accounting
fraud, or materially misleading information), consumer fraud
(including false advertising, defective products, or other
deceptive business practices), or anti-trust violations, please
email us at stockinfo@weisslawllp.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-investigates-cas-medical-systems-inc-300796736.html
SOURCE WeissLaw LLP